David Hickman

If you need to turn strong science into clinic-ready, investable assets, I help you do it with clarity, speed, and strategic focus.

I am a seasoned R&D leader with 25 years of experience advancing therapeutics and diagnostics across modalities from discovery through IND/CTA and into early clinical development. I work with biotech companies to strengthen development strategy, de-risk programs, and accelerate value creation at critical inflection points.

My expertise spans medicinal chemistry, pharmacology, translational science, CMC, early clinical development, cross-functional program leadership and portfolio strategy. I have moved multiple assets (therapeutics and diagnostics) from discovery to clinical development, aligning scientific rigor with regulatory expectations and investor priorities. At governance level, I support portfolio strategy, risk-based development planning, and data-driven decision-making to maximize asset value.

What sets me apart is my ability to integrate deep scientific insight with strategic execution. I bridge discovery and development, science and business, ensuring programs are not only technically sound but positioned for partnering, fundraising, and long-term success.

I advise Biotech, Pharma, VC-backed startups, or CRO’s on:

- Target-to-candidate strategy and execution

- Translational strategy

- IND / CTA strategy

- Clinical development plans & trial design

- CMC readiness

- Due diligence

- Program management

- Portfolio prioritization

Additionally services:

- Interim or fractional R&D leadership

- Scientific writing support for regulatory submissions and BD

- Competitive landscape analysis

I provide senior-level drug development expertise without the overhead of a full-time executive, helping you move forward with confidence and momentum.